central-nervous-system

Documents about central-nervous-system

• Induction Therapy With a Single High Dose Bolus of Intravenous Methotrexate With Leucovorin Rescue, Prior to Initiation of AVONEX® Treatment, in Patients Presenting With a First Acute Demyelinating Event.#885764ClinicalTrials.gov
• Tesetaxel Plus Reduced Dose of Capecitabine in Patients With HER2 Negative, HR Positive, LA/MBC#905221ClinicalTrials.gov
• Temozolomide in Treating Patients With Recurrent Glioblastoma Multiforme or Other Malignant Glioma#884057ClinicalTrials.gov
• Influenza Vaccine in Preventing Flu in Patients Who Have Undergone Stem Cell Transplant and in Healthy Volunteers#885719ClinicalTrials.gov
• Lonafarnib and Temozolomide in Treating Patients With Recurrent Primary Supratentorial Gliomas#911385ClinicalTrials.gov
• Pharmacokinetics in Patients With Newly Diagnosed High-Grade Glioma Receiving Temozolomide and Radiation Therapy#914043ClinicalTrials.gov
• Thiotepa Followed by Peripheral Stem Cell or Bone Marrow Transplant in Treating Patients With Malignant Glioma#831530ClinicalTrials.gov
• 3'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With Cancer#829464ClinicalTrials.gov
• Study of Genes and Environment in Patients With Cancer in East Anglia, Trent, or West Midlands Regions of the United Kingdom#1009530ClinicalTrials.gov
• Levofloxacin to Prevent Infection Following Chemotherapy in Treating Patients With Solid Tumors or Lymphoma#874670ClinicalTrials.gov
• A Multicenter, Open-label, Pilot Study of Soticlestat (TAK-935/OV935) in Participants With 15Q Duplication Syndrome (Dup 15q) or Cyclin-Dependent Kinase-Like 5 (CDKL5) Deficiency Disorder (ARCADE STUDY)#968990ClinicalTrials.gov
• Temozolomide in Treating Patients With Progressive Low-Grade Glioma#886757ClinicalTrials.gov
• Combination Chemotherapy Followed by Radiation Therapy in Treating Patients With Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Ependymoma#894649ClinicalTrials.gov
• An Analysis of the Response of Human Tumor Microvascular Endothelium to Ionizing Radiation#908236ClinicalTrials.gov
• Personalized Information or Basic Information in Helping Patients Make Decisions About Participating in a Clinical Trial#982035ClinicalTrials.gov
• A Study to Evaluate Tabelecleucel in Participants With Epstein Barr Virus (EBV) Associated Diseases#267993ClinicalTrials.gov
• An Open-label Study to Investigate ECUR-506 in Male Babies Less Than 9 Months of Age With Neonatal Onset OTC Deficiency#992088ClinicalTrials.gov
• Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Relapsed Germ Cell Cancer#893633ClinicalTrials.gov
• Temozolomide, Vincristine, and Irinotecan in Treating Young Patients With Refractory Solid Tumors#840076ClinicalTrials.gov
• ABT-888 and Temozolomide in Treating Young Patients With Recurrent or Refractory CNS Tumors#878938ClinicalTrials.gov
• A Study of FT-2102 in Patients With Advanced Solid Tumors and Gliomas With an IDH1 Mutation#849201ClinicalTrials.gov
• Intrathecal Rituximab in Treating Patients With Recurrent CNS Lymphoma#968340ClinicalTrials.gov
• Oxaliplatin and Irinotecan in Treating Young Patients With Refractory Solid Tumors or Lymphomas#992378ClinicalTrials.gov
• Radiation Therapy or Combination Chemotherapy in Treating Patients With Clinically or Radiologically Progressive Low-Grade Gliomas#811550ClinicalTrials.gov
• Decision Making About Participating in Pharmacokinetic Studies in Patients Enrolled in a Phase I Treatment Clinical Trial#917505ClinicalTrials.gov
• Topotecan in Treating Young Patients With Neoplastic Meningitis Due to Leukemia, Lymphoma, or Solid Tumors#844270ClinicalTrials.gov
• A Study Evaluating the Safety and Efficacy of GLPG5101 (19CP02) in Participants With Non-Hodgkin Lymphoma#845179ClinicalTrials.gov
• Gene Therapy and Chemotherapy in Treating Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma#841974ClinicalTrials.gov